The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
Official Title: A Prospective, Multi-Centre, Randomised, Open Parallel Group Study to Compare the Effectiveness and Compatibility of ARIMIDEX (ZD 1033) With NOLVADEX After a Prior 2 Years' Treatment With Tamoxifen in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
Study ID: NCT00287534
Brief Summary: The purpose of this study is to determine the efficacy and tolerability of 3 years treatment with anastrozole after a prior 2 years' treatment with tamoxifen versus 5 years treatment with tamoxifen in postmenopausal women with early breast cancer
Detailed Description:
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Research Site, Albstadt, , Germany
Research Site, Berlin, , Germany
Research Site, Cloppenburg, , Germany
Research Site, Eggenfelden, , Germany
Research Site, Frankfurt, , Germany
Research Site, Freiburg, , Germany
Research Site, Goettingen, , Germany
Research Site, Halle, , Germany
Research Site, Hamburg, , Germany
Research Site, Hanau, , Germany
Research Site, Hannover, , Germany
Research Site, Heidelberg, , Germany
Research Site, Hoyerswerda, , Germany
Research Site, Idar-Oberstein, , Germany
Research Site, Jena, , Germany
Research Site, Karlsruhe, , Germany
Research Site, Kassel, , Germany
Research Site, Kiel, , Germany
Research Site, Leonberg, , Germany
Research Site, Lingen, , Germany
Research Site, Luebeck, , Germany
Research Site, Magdeburg, , Germany
Research Site, Mainz, , Germany
Research Site, Mannheim, , Germany
Research Site, Muenchen, , Germany
Research Site, Muenster, , Germany
Research Site, Neustadt, , Germany
Research Site, Osnabrueck, , Germany
Research Site, Paderborn, , Germany
Research Site, Pforzheim, , Germany
Research Site, Recklinghausen, , Germany
Research Site, Rosenheim, , Germany
Research Site, Rostock, , Germany
Research Site, Ruesselsheim, , Germany
Research Site, Schleswig, , Germany
Research Site, Siegen, , Germany
Research Site, Titisee-Neustadt, , Germany
Research Site, Tuebingen, , Germany
Research Site, Ulm, , Germany
Research Site, Waiblingen, , Germany
Research Site, Westerstede, , Germany
Research Site, Worms, , Germany
Research Site, Wuerzburg, , Germany
Name: Manfred Kaufmann, MD
Affiliation: German Adjuvant Breast Cancer Group
Role: PRINCIPAL_INVESTIGATOR